Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-01-05 @ 6:36 PM
Study NCT ID:
NCT01464359
Status:
TERMINATED
Last Update Posted:
2017-12-28
First Post:
2011-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
T-Cell Depleted Double UCB for Refractory AML
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-01
First Submit QC Date:
None
Study First Post Date:
2011-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-29
Results First Submit QC Date:
None
Results First Post Date:
2015-05-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-03
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL